Application Nr Approved Date Route Status External Links
ANDA201382 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Guanfacine Extended-Release Tablets Are Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications [See Clinical Studies ( 14 )] . Guanfacine Extended-Release Tablets Are A Central Alpha 2a -Adrenergic Receptor Agonist Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications ( 1 , 14 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Guanfacine Hydrochloride GUANFACINE HYDROCHLORIDE ZINC3872738

Comments